Overview

This Study Aims to Use Convalescent Plasma as Experimental Treatment in Critically Ill Patients With Covid-19

Status:
Recruiting
Trial end date:
2021-06-25
Target enrollment:
Participant gender:
Summary
This study aims to collect convalescent plasma and use it as experimental treatment in critically ill Covid-19 patients in order to reduce mortality and length of stay in intensive care unit.
Phase:
Phase 2
Details
Lead Sponsor:
Hospital de Infecciosas Francisco Javier Muniz